Home> Products> patients begin

{ "products": [ { "_id": "6864fe81c4418d1ebb0d08eb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIS DPI DEVICE", "description": "The STERIS DPI DEVICE is a modern, user-friendly Dry Powder Inhaler (DPI) designed to deliver respiratory medication directly to the lungs in a highly efficient and portable form. Inhalation therapy plays a critical role in the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The DPI device simplifies this process by delivering the drug in the form of a dry powder without the need for coordination between actuation and inhalation, making it ideal for patients of all ages.\n\nWhat is a DPI Device?\nA Dry Powder Inhaler (DPI) is a medical device used to deliver therapeutic medication directly into the lungs. Unlike traditional inhalers that use propellants to push the drug into the lungs, DPI devices rely on the patient’s own inhalation power to disperse and inhale the powdered drug effectively. Essentially, a DPI device is a tool that administers medication in dry powder form to the lungs, providing quick and targeted respiratory relief.\n\nDPI Full Form: Dry Powder Inhaler\n\nUses of STERIS DPI DEVICE\nThe STERIS DPI DEVICE is commonly used in the treatment and management of respiratory diseases such as:\n\nAsthma\n\nChronic Obstructive Pulmonary Disease (COPD)\n\nBronchitis\n\nAllergic airway conditions\n\nIt helps deliver medication directly to the airways, ensuring faster action and reduced systemic side effects compared to oral treatments.\n\nHow It Works\nWhen the patient inhales through the mouthpiece, the device uses the airflow to disperse the dry powder into fine particles, allowing it to reach deep into the lungs. The inhaled medication begins working quickly to open airways, reduce inflammation, or treat infection, depending on the formulation used with the DPI.\n\nSide Effects of Dry Powder Inhaler Use\nWhile the STERIS DPI DEVICE itself is safe and user-friendly, some medications delivered via DPI may cause minor side effects such as:\n\nDry throat or mouth\n\nHoarseness\n\nCough\n\nIrritation in the throat\n\nFungal infections in the mouth (if corticosteroids are used and mouth is not rinsed after use)\n\nThese side effects can often be minimized with proper usage and hygiene.\n\nPrecautions Before Using STERIS DPI DEVICE\nAlways read the instructions carefully before first-time use.\n\nMake sure the device is clean and free from moisture.\n\nInhale deeply and forcefully to ensure proper medication delivery.\n\nDo not exhale into the device, as moisture can affect the powder's consistency.\n\nStore in a dry, cool place away from direct sunlight.\n\nAlways rinse your mouth after using corticosteroid-based powders.\n\nAdvantages of STERIS DPI DEVICE\nPropellant-free and eco-friendly\n\nPortable and compact design for daily use\n\nNo coordination required between inhalation and actuation\n\nDelivers medication effectively with minimal effort\n\nEasy-to-use, even for elderly or pediatric patients\n\nConclusion\nThe STERIS DPI DEVICE is a highly effective solution for individuals suffering from chronic or acute respiratory disorders. By delivering medication directly to the lungs in a dry powder form, it ensures fast relief, greater bioavailability, and improved patient compliance. Whether you’re managing asthma or COPD, this DPI device offers a dependable and convenient way to breathe easier every day.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "coordination required", "inhalation power", "inhalation making", "breathe easier", "individuals suffering", "compact design", "ecofriendly portable", "direct sunlight", "instructions carefully", "hygiene precautions", "proper usage", "medications delivered", "reach deep", "oral treatments", "critical role", "medical device", "patient inhales", "administers medication", "highly efficient", "respiratory diseases", "dpi device", "dry throat", "dry powder", "side effects", "moisture inhale deeply", "delivering medication directly", "lungs providing quick", "dry powder form", "chronic respiratory conditions", "pediatric patients conclusion", "dpi device offers", "dpi device simplifies", "steris dpi device", "dpi side effects", "youre managing asthma", "dry powder inhaler", "minor side effects", "improved patient compliance", "highly effective solution", "throat fungal infections", "dry cool place", "acute respiratory disorders", "minimal effort easytouse", "corticosteroidbased powders advantages", "powders consistency store", "treat infection depending", "fine particles allowing" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2142, "imageuri": "https://productimages.withfloats.com/actual/6864feb4c75fa610aeaeaeda.png", "tileimageuri": "https://productimages.withfloats.com/tile/6864feb4c75fa610aeaeaeda.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-02T09:40:17.078Z", "updatedon": "2025-07-02T13:03:34.654Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/steris-dpi-device/2142", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dry powder inhaler", "category": "RESPIRTORYRANGE", "tags": [ "Dry powder inhaler" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6819f2b5b631af66ff847b24", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ORAVERSE M", "description": "ORAVERSE M is a meticulously formulated health supplement combining Myo-inositol (600 mg) with Metformin Hydrochloride (500 mg), specifically developed to boost metabolic wellness, particularly for those affected by polycystic ovary syndrome (PCOS) and insulin resistance. This dual-component preparation addresses hormonal equilibrium, glucose utilization, and ovarian health, providing a thorough solution for enhancing reproductive and metabolic functioning. Healthcare professionals frequently recommend it as part of treatment strategies for women with PCOS or individuals struggling with insulin sensitivity and irregular ovulation patterns.\nEssential Components:\n\nMyo-inositol IP (600 mg): A nutrient resembling vitamins (within the B-complex family), Myo-inositol serves a crucial function in cellular communication, particularly insulin signal transmission. It's recognized for its positive influence on ovarian activity, hormone regulation, and metabolic function.\nMetformin Hydrochloride (500 mg): A proven anti-diabetic medicine that helps reduce blood sugar and enhance insulin effectiveness. It's widely prescribed for Type 2 diabetes mellitus and PCOS-related insulin resistance.\n\nPrimary Advantages:\n\nBoosts Insulin Response: Both Myo-inositol and Metformin function complementarily to improve insulin sensitivity and reduce resistance, a key factor in metabolic disorders and PCOS.\nRegulates Menstrual Cycles & Ovulation: Particularly valuable for PCOS patients, ORAVERSE M may help normalize menstrual patterns and encourage ovulation.\nSupports Ovarian Health: Myo-inositol aids follicular development and egg quality, potentially enhancing fertility prospects.\nAlleviates High Androgen Symptoms: Helps manage manifestations like acne, excessive body hair, and hair thinning caused by elevated male hormone levels in PCOS.\nSupports Weight Management: Enhances metabolic factors that contribute to better weight control, especially for those with insulin resistance.\nReduces Diabetes Risk: By improving blood sugar regulation and lowering insulin levels, this formulation may help prevent progression to diabetes.\n\nFunctional Mechanism:\nORAVERSE M operates through a complementary action:\n\nMyo-inositol enhances insulin signaling at the cellular level, supporting glucose uptake and metabolism. It also influences luteinizing hormone (LH) and follicle-stimulating hormone (FSH) regulation, helping restore hormonal balance critical in PCOS.\nMetformin Hydrochloride decreases liver glucose production and increases insulin sensitivity in muscle and fat tissues, resulting in improved blood sugar control. For women with PCOS, Metformin also helps normalize menstrual cycles and ovulation.\n\nTogether, these ingredients help restore metabolic and reproductive wellness by addressing the root causes of PCOS and related metabolic disruptions.\nUsage Guidelines:\n\nStandard Dosage: One ORAVERSE M tablet is typically taken once or twice daily, as recommended by a physician.\nAdministration Method: Take with meals to minimize digestive discomfort. Swallow whole with water—avoid crushing or chewing.\nImportant: Always follow your healthcare provider's specific instructions regarding dosage and treatment duration.\n\nPotential Side Effects:\nORAVERSE M is generally well-tolerated, though some users may experience effects, particularly when beginning treatment:\n\nCommon Reactions:\n\nNausea\nBloating or gas\nMild diarrhea\nStomach discomfort\nMetallic taste (Metformin-related)\n\n\nLess Common but Significant:\n\nVitamin B12 deficiency (with prolonged Metformin use)\nMild dizziness or headache\nLow blood sugar (uncommon, especially when combined with other diabetes medications)", "price": 275.0, "discountamount": 83.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "diabetes medications", "mild dizziness", "experience effects", "generally welltolerated", "chewing important", "wateravoid crushing", "prevent progression", "weight control", "key factor", "reduce resistance", "widely prescribed", "positive influence", "cellular communication", "individuals struggling", "treatment strategies", "enhancing reproductive", "oraverse moraverse", "pcos metformin", "prolonged metformin", "restore metabolic", "metabolic disorders", "reproductive wellness", "crucial function", "insulin resistance", "insulin sensitivity", "pcos patients oraverse", "metformin function complementarily", "boost metabolic wellness", "increases insulin sensitivity", "improve insulin sensitivity", "lowering insulin levels", "enhance insulin effectiveness", "insulin signal transmission", "physician administration method", "fat tissues resulting", "hair thinning caused", "normalize menstrual patterns", "proven antidiabetic medicine", "nutrient resembling vitamins", "ovarian health providing" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2102, "imageuri": "https://productimages.withfloats.com/actual/6819f2b79d6e117a7e9250d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6819f2b79d6e117a7e9250d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-06T11:29:57.58Z", "updatedon": "2025-05-06T11:29:57.58Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/oraverse-m/2102", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Myo-inositol IP (600 mg), Metformin Hydrochloride (500 mg)", "category": "Gynaecology", "tags": [ "myo-inositol 600 mg & metformin hydrochloride 500 mg (sustained release) tablets", "Myo-Inositol 600 mg and Metformin hydrochloride 500 mg Uses in Hindi", "myo-inositol 600 mg & metformin hydrochloride 500 mg uses", "myo-inositol 600 mg & metformin hydrochloride 500 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6819e619af35b11ab7f87163", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BUDEPRESS FORTE 400 CAPSULES", "description": "BUDEPRESS FORTE 400 combines powerful inhalation therapy ingredients to manage asthma and chronic obstructive pulmonary disease (COPD). This medication contains Formoterol Fumarate (12 mcg) and Budesonide IP (400 mcg), working together to alleviate and prevent respiratory symptoms including wheezing, shortness of breath, chest constriction, and chronic coughing. It delivers both sustained control and quick symptom relief, enhancing lung function and life quality.\nActive Components:\nFormoterol Fumarate (12 mcg)\nA long-acting beta-2 adrenergic agonist (LABA) that delivers quick and extended bronchodilation by relaxing airway muscles. Effects begin within minutes and continue for up to 12 hours, making it excellent for ongoing therapy.\nBudesonide IP (400 mcg)\nA strong inhaled corticosteroid (ICS) that reduces lung inflammation, swelling, and mucus production—primary factors contributing to asthma and COPD symptoms.\nPrimary Advantages:\nCombination therapy featuring both bronchodilator and anti-inflammatory for comprehensive respiratory management.\nQuick relief from bronchial constriction and breathing difficulties.\nExtended symptom control lasting up to 12 hours with regular administration.\nReduces asthma attack frequency and COPD flare-up severity.\nEnhances respiratory function for easier, more comfortable breathing.\nRequires fewer daily doses compared to short-acting alternatives.\nAppropriate for moderate to severe respiratory conditions under medical guidance.\nMechanism of Action:\nBUDEPRESS FORTE 400 operates through complementary actions of its two key ingredients:\nFormoterol Fumarate eases bronchial tube smooth muscles, creating airway expansion and rapid relief from narrowing that causes breathing distress.\nBudesonide, as an anti-inflammatory steroid, addresses underlying airway inflammation causing chronic symptoms and exacerbations. It diminishes hyperresponsiveness and mucus accumulation with consistent use.\nTogether, they prevent airway tightening, decrease inflammation, and facilitate smooth airflow, offering better management of chronic respiratory conditions.\nUsage Instructions:\nUse only as prescribed by your healthcare provider.\nTypically administered twice daily (morning and evening), though dosage may vary based on condition severity and individual response.\nShake inhaler thoroughly before each use.\nRinse mouth completely with water after each use to avoid oral thrush (fungal infection).\nNever exceed the prescribed dosage.\nFor effective management, maintain consistent use even when symptoms improve.\nPotential Side Effects:\nMost patients tolerate BUDEPRESS FORTE 400 well, though side effects may occur:\nCommon Effects:\n\nVoice changes or hoarseness\nDry mouth or throat irritation\nCoughing or throat discomfort\nHeadache\nMild trembling or shakiness\nElevated heart rate (palpitations)\n\nLess Common but Serious Effects:\n\nOral or throat fungal infection (thrush)\nAllergic responses (rash, swelling, breathing difficulty)\nMuscle cramping\nChest discomfort\nWorsening respiratory issues (paradoxical bronchospasm)\n\nContact your physician immediately for persistent or severe side effects.\nImportant Precautions:\nNot for acute asthma attack treatment—always maintain a rescue inhaler for emergencies.\nInform your doctor about heart conditions, diabetes, thyroid disorders, or liver issues.\nAvoid exposure to contagious diseases (e.g., chickenpox, measles) while using corticosteroid therapy.\nPregnant or nursing women should consult healthcare providers before using.\nStore securely away from children.\nBUDEPRESS FORTE 400 provides a clinically validated, dual-action approach to respiratory comfort—combining immediate relief with long-term management. With proper medical supervision, it significantly improves daily activity levels and decreases respiratory symptom burden.", "price": 940.0, "discountamount": 282.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 hours", "prescribed dosage", "longterm management", "rapid relief", "12 hours making", "delivers quick", "manage asthma", "store securely", "nursing women", "chickenpox measles", "contagious diseases", "emergencies inform", "rescue inhaler", "physician immediately", "effects oral", "side effects", "condition severity", "vary based", "daily morning", "mucus accumulation", "diminishes hyperresponsiveness", "complementary actions", "shortacting alternatives", "extended bronchodilation", "sustained control", "wheezing shortness", "bronchial constriction", "chronic coughing", "respiratory comfortcombining", "throat irritation coughing", "breath chest constriction", "severe respiratory conditions", "prevent respiratory symptoms", "proper medical supervision", "consult healthcare providers", "corticosteroid therapy pregnant", "hoarseness dry mouth", "rinse mouth completely", "breathing distress budesonide", "medical guidance mechanism" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2101, "imageuri": "https://productimages.withfloats.com/actual/6819e61c974ab387c1d08df8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6819e61c974ab387c1d08df8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-06T10:36:09.795Z", "updatedon": "2025-05-06T10:36:09.795Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/budepress-forte-400-capsules/2101", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Formoterol Fumarate (12 mcg), Budesonide IP (400 mcg)", "category": "ASTHMARANGE", "tags": [ "Formoterol fumarate and budesonide powder for inhalation ip", "Formoterol fumarate and Budesonide powder for inhalation ip uses", "Formoterol fumarate and budesonide inhaler dosage", "Formoterol fumarate and Budesonide Powder for Inhalation IP 400" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67f65773416f03578685810d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Isosorbide Mononitrate 40 mg", "description": "CARDULES ISMN SR 40 is a sustained-release tablet formulated with Isosorbide Mononitrate (40 mg), a powerful nitrate-based compound used primarily in the prevention and long-term management of angina pectoris (chest pain caused by heart disease). This medication works by relaxing and widening blood vessels, allowing for improved blood flow to the heart, reducing its workload, and preventing episodes of chest pain. It is typically prescribed for patients with chronic stable angina and forms part of a long-term treatment plan for certain heart conditions.\n\n\nKey Benefits:\n\n\nHelps prevent and manage angina (chest pain) in patients with coronary artery disease.\n\nImproves blood flow to the heart muscles, reducing the risk of cardiac ischemia.\n\nDecreases the oxygen demand on the heart by reducing preload and afterload.\n\nOffers long-lasting relief with a sustained-release action for convenience and steady plasma levels.\n\nReduces the frequency of anginal attacks, enhancing quality of life and exercise tolerance.\n\n\nHow Does It Work?\n\n\nIsosorbide Mononitrate, the active ingredient in CARDULES ISMN SR 40, is converted into nitric oxide in the body. Nitric oxide activates guanylate cyclase, leading to increased levels of cyclic GMP (cGMP). This compound causes relaxation of vascular smooth muscles, primarily in the veins and arteries, resulting in vasodilation. As a result, blood flows more freely to the heart with reduced pressure, decreasing the heart's workload and helping to prevent episodes of angina. The sustained-release formulation ensures a prolonged therapeutic effect, minimizing fluctuations in drug levels throughout the day.\n\nDirections for Use\nTake CARDULES ISMN SR 40 exactly as prescribed by your doctor.\n\nSwallow the tablet whole with a glass of water, preferably at the same time each day.\n\nDo not crush, chew, or break the tablet as it is designed for slow release over time.\n\nIt is typically taken once daily, but the dosage may vary depending on individual medical conditions.\n\nAvoid taking the tablet on an empty stomach unless advised by your healthcare provider.\n\nDo not suddenly stop taking the medication without consulting your doctor.\n\n\nSide Effects:\n\n\nLike all medications, CARDULES ISMN SR 40 may cause some side effects, although not everyone experiences them. Common side effects include:\n\nHeadache (especially at the beginning of treatment).\n\nDizziness or lightheadedness.\n\nFlushing of the skin.\n\nNausea or vomiting.\n\nFatigue.\n\nLow blood pressure (hypotension).\n\nIn rare cases, severe allergic reactions or fainting may occur. Contact your healthcare provider immediately if you experience chest pain that doesn't improve, irregular heartbeat, or signs of an allergic reaction like rash, itching, or swelling.", "price": 73.0, "discountamount": 22.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "typically prescribed", "day directions", "hearts workload", "medication works", "heart disease", "rash itching", "allergic reaction", "occur contact", "skin nausea", "lightheadedness flushing", "empty stomach", "vary depending", "slow release", "crush chew", "water preferably", "drug levels", "prevent episodes", "arteries resulting", "increased levels", "nitric oxide", "active ingredient", "exercise tolerance", "oxygen demand", "forms part", "preventing episodes", "heart reducing", "reducing preload", "treatment dizziness", "doctor swallow", "longterm management", "sustainedrelease action", "healthcare provider", "chest pain", "side effects", "heart muscles reducing", "sustainedrelease tablet formulated", "doctor side effects", "experience chest pain", "healthcare provider immediately", "longterm treatment plan", "chronic stable angina", "powerful nitratebased compound", "common side effects", "sustainedrelease formulation ensures", "suddenly stop taking", "reduced pressure decreasing", "result blood flows", "cyclic gmp cgmp", "work isosorbide mononitrate", "cardiac ischemia decreases", "improved blood flow" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2078, "imageuri": "https://productimages.withfloats.com/actual/67f657744062f07a5185c6ad.png", "tileimageuri": "https://productimages.withfloats.com/tile/67f657744062f07a5185c6ad.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-09T11:18:11.501Z", "updatedon": "2025-04-09T11:18:11.501Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/isosorbide-mononitrate-40-mg/2078", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CARDULES ISMN SR 40", "category": "CARDIOLOGYRANGE", "tags": [ "What is isosorbide mononitrate 30 mg used for", "Isosorbide mononitrate 10mg", "Isosorbide mononitrate 30 mg side effects", "Isosorbide mononitrate 5 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "672b543a2776dcaeeefae958", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Megestrol Acetate 40 mg", "description": "MAGRAL 40 is a specialized formulation containing Megestrol Acetate (40 mg), a synthetic progestin commonly used to help manage symptoms associated with certain medical conditions, including appetite loss and specific types of cancer. Megestrol Acetate is known for its appetite-stimulating properties, making MAGRAL 40 beneficial for patients experiencing weight loss due to chronic illness. This medication works by influencing certain hormones and pathways in the body to provide therapeutic effects that improve quality of life.\n\n \nKey Benefits:\n \n\nAppetite Stimulation: One of the primary benefits of MAGRAL 40 is its ability to increase appetite, helping patients regain lost weight and improve nutritional intake.\nManagement of Cancer Symptoms: Megestrol Acetate can help alleviate certain symptoms in hormone-responsive cancers, offering supportive care for patients managing breast or endometrial cancer.\nSupport in Chronic Illness: For patients experiencing cachexia or wasting associated with illnesses such as AIDS, MAGRAL 40 can provide relief by promoting weight gain and improving energy levels.\nHormone Regulation: As a progestin, Megestrol Acetate also influences hormone levels in the body, which can help in managing symptoms in specific medical conditions.\n \nHow Does It Work?\n \n\nMAGRAL 40 works primarily by mimicking the effects of the natural hormone progesterone. Megestrol Acetate interacts with certain hormone receptors in the body, affecting the hypothalamus and other regulatory systems to stimulate appetite and weight gain. This action is particularly beneficial in patients experiencing involuntary weight loss. Additionally, by affecting hormone levels, MAGRAL 40 helps slow the growth of hormone-sensitive cancers, such as breast and endometrial cancers, providing relief from symptoms and aiding in disease management.\n\n \nDirections for Use:\n \n\nRecommended Dosage: Take MAGRAL 40 exactly as prescribed by your healthcare provider. Dosage varies based on individual needs and medical condition.\nAdministration: Swallow the tablet with water. It can be taken with or without food, though consistency is recommended for optimal absorption.\nTiming: Follow your healthcare provider’s instructions on frequency and duration. Typically, it is taken once daily or as advised.\nMissed Dose: If you miss a dose, take it as soon as you remember. If it’s close to your next dose, skip the missed dose and resume your regular schedule. Avoid doubling up on doses.\nStorage: Store MAGRAL 40 in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.\n \nSide Effects:\n \n\nWhile MAGRAL 40 is generally well-tolerated, some users may experience side effects, including:\n\nWeight Gain: As an appetite stimulant, it is common to experience an increase in body weight.\nNausea and Vomiting: Mild gastrointestinal discomfort may occur, especially at the beginning of treatment.\nMood Changes: Some patients may experience mild mood swings or changes in mental alertness.\nFatigue: Fatigue or tiredness may be noted, especially with long-term use.\nHormonal Side Effects: In rare cases, changes in menstrual cycles or other hormone-related effects may occur.", "price": 300.0, "discountamount": 90.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "40 mg", "next dose", "rare cases", "body weight", "weight gain", "Mood Changes", "Key Benefits", "long-term use", "appetite loss", "energy levels", "hormone levels", "specific types", "Cancer Symptoms", "direct sunlight", "supportive care", "chronic illness", "cool, dry place", "menstrual cycles", "mental alertness", "regular schedule", "individual needs", "primary benefits", "mild mood swings", "Megestrol Acetate", "hormone receptors", "Recommended Dosage", "disease management", "appetite stimulant", "optimal absorption", "nutritional intake", "Hormone Regulation", "synthetic progestin", "healthcare provider", "endometrial cancers", "therapeutic effects", "Appetite Stimulation", "Hormonal Side Effects", "specialized formulation", "involuntary weight loss", "other regulatory systems", "hormone-sensitive cancers", "hormone-responsive cancers", "specific medical conditions", "natural hormone progesterone", "other hormone-related effects", "appetite-stimulating properties", "Mild gastrointestinal discomfort" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2024, "imageuri": "https://productimages.withfloats.com/actual/672b547c9e5dd930f66a2c88.png", "tileimageuri": "https://productimages.withfloats.com/tile/672b547c9e5dd930f66a2c88.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-11-06T11:34:18.872Z", "updatedon": "2024-11-06T11:34:18.872Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/megestrol-acetate-40-mg/2024", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MAGRAL 40 ", "category": "gynaecology", "tags": [ "What is megestrol 40 mg used for", "", "Megestrol acetate 40 mg side effects", "Megestrol acetate side effects", "Megestrol Acetate 40 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ab64ed0d0330684bdba32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MIRTAZPRIME 7.5 ", "description": "MIRTAZPRIME 7.5 \nMirtazapine (7.5mg)\nIntroduction:\n\nMIRTAZPRIME 7.5 contains Mirtazapine (7.5 mg), an antidepressant medication primarily used to treat major depressive disorder (MDD) and anxiety disorders. Mirtazapine belongs to a class of medications known as tetracyclic antidepressants and works by balancing chemicals in the brain that affect mood.\nKey Features and Benefits:\n\nEffective Antidepressant: Mirtazapine is highly effective in alleviating symptoms of depression, including persistent sadness, loss of interest in activities, and feelings of hopelessness.\nAnxiety Relief: Besides treating depression, Mirtazapine is beneficial for managing anxiety symptoms, providing a calming effect and reducing anxiety levels.\nImproved Sleep: Mirtazapine has sedative properties, which can help improve sleep patterns in individuals with insomnia related to depression or anxiety.\nAppetite Stimulation: Mirtazapine can stimulate appetite, making it useful for patients experiencing weight loss or poor appetite due to depression.\nRapid Onset: Mirtazapine often begins to show benefits within one to two weeks of starting treatment, offering quicker relief from depressive symptoms compared to some other antidepressants.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of MIRTAZPRIME 7.5 is 7.5 mg taken once daily, usually at bedtime due to its sedative effects.\nMaintenance Dosage: The dosage may be gradually increased by a healthcare provider based on the patient's response to treatment. The usual maintenance dose ranges from 15 mg to 45 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Mirtazapine at the same time each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/mirtazprime-7-5-133587", "price": 65.0, "discountamount": 19.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "MDD", "mood", "food", "class", "brain", "EMAIL", "water", "45 mg", "15 mg", "tablet", "7.5 mg", "bedtime", "Benefits", "interest", "feelings", "insomnia", "patients", "response", "treatment", "same time", "chemicals", "activities", "depression", "medications", "Mirtazapine", "MIRTAZPRIME", "bloodstream", "information", "Rapid Onset", "individuals", "weight loss", "sterispharma", "hopelessness", "Introduction", "sterisonline", "Key Features", "poor appetite", "CALL/WHATSAPP", "Improved Sleep", "Initial Dosage", "anxiety levels", "Anxiety Relief", "calming effect", "Administration", "sleep patterns", "quicker relief", "anxiety symptoms", "one to two weeks", "sedative effects", "anxiety disorders", "Maintenance Dosage", "persistent sadness", "depressive symptoms", "healthcare provider", "sedative properties", "Appetite Stimulation", "other antidepressants", "typical starting dose", "usual maintenance dose", "Effective Antidepressant", "antidepressant medication", "major depressive disorder", "tetracyclic antidepressants", "consistent medication levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1855, "imageuri": "https://productimages.withfloats.com/actual/667d168dbd53863fb364f7ea.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d168dbd53863fb364f7ea.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:05:18.43Z", "updatedon": "2024-06-27T07:36:44.93Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mirtazprime-7-5-/1855", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIRTAZPRIME 7.5 ", "category": "NEUROLOGYRANGE", "tags": [ "mirtazapine warnings", "mirtazapine 7.5 uses in hindi", "mirtaz 7.5 side effects", "mirtaz 7.5 benefits", "mirtazapine for sleep" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ab4987e4bb91e30921215", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MIRTAZPRIME 15 ", "description": "MIRTAZPRIME 15 \nMirtazapine (15mg)\nIntroduction:\n\nMIRTAZPRIME 15 contains Mirtazapine (15 mg), an antidepressant medication primarily used to treat major depressive disorder (MDD) and anxiety disorders. Mirtazapine belongs to a class of medications known as tetracyclic antidepressants and works by balancing chemicals in the brain that affect mood.\nKey Features and Benefits:\n\nEffective Antidepressant: Mirtazapine is highly effective in alleviating symptoms of depression, including persistent sadness, loss of interest in activities, and feelings of hopelessness.\nAnxiety Relief: Besides treating depression, Mirtazapine is beneficial for managing anxiety symptoms, providing a calming effect and reducing anxiety levels.\nImproved Sleep: Mirtazapine has sedative properties, which can help improve sleep patterns in individuals with insomnia related to depression or anxiety.\nAppetite Stimulation: Mirtazapine can stimulate appetite, making it useful for patients experiencing weight loss or poor appetite due to depression.\nRapid Onset: Mirtazapine often begins to show benefits within one to two weeks of starting treatment, offering quicker relief from depressive symptoms compared to some other antidepressants.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of MIRTAZPRIME 15 is 15 mg taken once daily, usually at bedtime due to its sedative effects.\nMaintenance Dosage: The dosage may be gradually increased by a healthcare provider based on the patient's response to treatment. The usual maintenance dose ranges from 15 mg to 45 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Mirtazapine at the same time each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/mirtazprime-15-133586", "price": 89.0, "discountamount": 26.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "day", "food", "mood", "15 mg", "EMAIL", "water", "45 mg", "brain", "class", "tablet", "bedtime", "interest", "feelings", "insomnia", "patients", "Benefits", "response", "treatment", "same time", "chemicals", "activities", "depression", "weight loss", "MIRTAZPRIME", "medications", "Rapid Onset", "individuals", "bloodstream", "information", "Mirtazapine", "sterispharma", "hopelessness", "sterisonline", "Key Features", "Introduction", "CALL/WHATSAPP", "poor appetite", "anxiety levels", "calming effect", "Administration", "sleep patterns", "quicker relief", "Improved Sleep", "Initial Dosage", "Anxiety Relief", "anxiety symptoms", "sedative effects", "one to two weeks", "anxiety disorders", "persistent sadness", "Maintenance Dosage", "sedative properties", "healthcare provider", "depressive symptoms", "Appetite Stimulation", "typical starting dose", "other antidepressants", "usual maintenance dose", "Effective Antidepressant", "antidepressant medication", "major depressive disorder", "tetracyclic antidepressants", "consistent medication levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1854, "imageuri": "https://productimages.withfloats.com/actual/666ab49bf068be46bdeac897.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ab49bf068be46bdeac897.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T08:58:00.24Z", "updatedon": "2024-06-26T10:59:13.26Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mirtazprime-15-/1854", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIRTAZPRIME 15 ", "category": "NEUROLOGYRANGE", "tags": [ "mirtazapine 15mg side effects", "Mirtazapine (15mg)", "", "mirtazapine 15 mg used for", "mirtazapine warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66695a64b453b6167c504598", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BVM GOLD 100 ", "description": "BVM GOLD 100 \nBrivaracetam (100mg)\nIntroduction\nBVM GOLD 100 contains Brivaracetam (100mg), an antiepileptic medication used for the treatment of partial-onset seizures in patients with epilepsy. Brivaracetam is known for its high efficacy and favorable safety profile, making it a preferred choice for managing seizures and improving the quality of life for individuals with epilepsy.\n\nKey Ingredient and Its Benefits\nBrivaracetam (100mg)\nAntiepileptic Properties: Brivaracetam works by binding to synaptic vesicle protein 2A (SV2A) in the brain, which helps to stabilize neural activity and prevent seizures.\nPartial-Onset Seizures: It is particularly effective in controlling partial-onset seizures, which begin in a specific area of the brain and can spread to other regions.\nRapid Onset of Action: Brivaracetam has a rapid onset of action, providing quick relief from seizures and reducing seizure frequency.\nWell-Tolerated: The medication is generally well-tolerated, with a low incidence of side effects compared to other antiepileptic drugs.\nBenefits of BVM GOLD 100\nEffective Seizure Control: BVM GOLD 100 provides effective control of partial-onset seizures, reducing their frequency and severity.\nRapid Relief: The rapid onset of action ensures quick relief from seizures, improving the patient's immediate safety and comfort.\nImproved Quality of Life: By effectively managing seizures, BVM GOLD 100 helps enhance the overall quality of life for individuals with epilepsy, allowing them to lead more active and fulfilling lives.\nWell-Tolerated: Brivaracetam is well-tolerated, with fewer side effects compared to many other antiepileptic medications, making it suitable for long-term use.\nDosage and Administration\nDosage\nPartial-Onset Seizures: The typical starting dosage for partial-onset seizures in adults and adolescents aged 16 years and older is one tablet (100mg) taken twice daily. The dosage may be adjusted by the healthcare provider based on the patient's response and tolerability, with a maximum recommended dose of 200mg twice daily.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It can be taken with or without food.\nConsistency: For optimal results, take BVM GOLD 100 at the same times each day to maintain an even level of the medication in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/bvm-gold-100-133541", "price": 504.0, "discountamount": 151.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "SV2A", "food", "dose", "water", "Order", "EMAIL", "brain", "level", "200mg", "Action", "adults", "choice", "active", "maximum", "binding", "comfort", "Oral Use", "Benefits", "epilepsy", "bvm-gold", "patients", "response", "severity", "treatment", "full glass", "same times", "one tablet", "Rapid Onset", "adolescents", "Consistency", "individuals", "bloodstream", "information", "tolerability", "sterispharma", "Brivaracetam", "sterisonline", "BVM GOLD 100", "Introduction", "quick relief", "Rapid Relief", "CALL/WHATSAPP", "other regions", "high efficacy", "specific area", "long-term use", "low incidence", "Key Ingredient", "neural activity", "optimal results", "overall quality", "fulfilling lives", "Improved Quality", "immediate safety", "effective control", "seizure frequency", "fewer side effects", "healthcare provider", "Administration Dosage", "partial-onset seizures", "typical starting dosage", "favorable safety profile", "Antiepileptic Properties", "Effective Seizure Control", "other antiepileptic drugs", "synaptic vesicle protein 2A", "many other antiepileptic medications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1783, "imageuri": "https://productimages.withfloats.com/actual/66695adc117f82c50b08bb69.png", "tileimageuri": "https://productimages.withfloats.com/tile/66695adc117f82c50b08bb69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T08:20:52.634Z", "updatedon": "2024-06-27T07:32:02.03Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/bvm-gold-100-/1783", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BVM GOLD 100 ", "category": "NEUROLOGY RANGE", "tags": [ "Brivaracetam (100mg)", "", "Brivaracetam (100mg) PRICE", "brivaracetam 100 mg uses in hindi", "brivaracetam injection" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }